AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lucid Diagnostics Inc. Director's Dealing 2023

Apr 6, 2023

33983_dirs_2023-04-06_92e08963-f2bb-43e9-9179-67a489933da1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2022-03-18

Reporting Person: O'Neil Shaun (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	120000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee stock option (right to buy)	$3.95	2032-02-18	Common stock (50000)		Direct

Footnotes

F1: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of January 7, 2025. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

F2: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022.